300206.SZ
300206.SZ
CNE100001252
EDAN
Loading chart...

Company Profile

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, telemetry and IT products; and obstetrics, pelvic floor rehabilitation, and gynecology products. It also provides ultrasound systems that include cart-based color doppler, portable color doppler, and B/W ultrasound systems; and in-vitro diagnostics, which comprise hematology and reagents. In addition, the company offers point-of-care testing systems, including blood gas and chemistry analyzers, disposable arterial blood samplers, and blood gas capillary tubes; and veterinary ultrasound, ECG, laboratory, and monitoring products. Edan Instruments, Inc. was founded in 1995 and is headquartered in Shenzhen, China.

Related stocks

2697.HK
2697.HK • China
TH MEDICAL-B
183 HKD
1.2B USD
688626.SS
688626.SS • China
XIANGYU MEDICAL CO LTD
40.49 CNY
969.39M USD 1Y -22.7%
301367.SZ
301367.SZ • China
BMC
46.71 CNY
875.66M USD 1Y -20.4%
2190.HK
2190.HK • China
ZYLOXTB
20.5 HKD
861.68M USD 1Y -17.1%
2675.HK
2675.HK • China
EDGE MEDICAL-B
33 HKD
1.64B USD
300143.SZ
300143.SZ • China
INKON LIFE
7.95 CNY
1.16B USD 1Y -9%
688139.SS
688139.SS • China
QINGDAO HAIER BIOMEDICAL CO LTD
35.13 CNY
1.66B USD 1Y +4.9%
300482.SZ
300482.SZ • China
WONDFO BIOTECH
16.74 CNY
1.17B USD 1Y -22%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
44.0% p.a.
Max Drawdown (5Y)
-53.6%
Sharpe Ratio (5Y)
-0.07
Beta Factor
0.52
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -72.2% in the extended horizon.
ende